The convergence of IoT, AI, and advanced materials is fueling unprecedented demand for smart sensors capable of real-time, ultra-sensitive detection. Industries face pressure to enhance product safety, ensure environmental compliance, and deliver personalized health solutions. This technology directly addresses these challenges by offering a cost-effective pathway to upgrade existing sensor infrastructure, enabling rapid deployment of next-generation diagnostic and monitoring tools that meet evolving global standards and consumer expectations.
Increases sensor sensitivity by up to 3x for trace substance detection without new receptor development.
Enhances sensor versatility by modulating response characteristics for multiple analytes with a single receptor.
Reduces R&D time and costs by up to 50% by eliminating the need for new receptor development.
This patent has been meticulously compared against five prior art documents by the examiner and found to be patentable, establishing a stable rights foundation with low risk of future challenges. It features 12 claims, providing broad technical protection from the receptor response modulation method to the measurement device, backed by robust fundamental research from NIMS.
This patent primarily covers the modulation method and device for nanomechanical sensors. White space exists for integrating this technology with other sensor types or developing novel applications in areas like in-vivo diagnostics or advanced material characterization.
High sensitivity enables measurement of trace substances previously undetectable, potentially creating a new diagnostic service market of ~$1.0M/year (AI est.). Additionally, the technology could reduce average annual receptor development costs of ~$1.5M (AI est.) by ~75%, leading to a total economic impact of ~$2.0M/year (AI est.).
X: Technological Innovation
Y: Cost Efficiency